JeffreyT.YorioMD

PubMed

• A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma.
  Msaouel, P., Sweis, R., Bupathi, M., Heath, E., Goodman, O., Hoimes, C., Milowsky, M., Davis, N., Kalebasty, A., Picus, J., Shaffer, D., Mao, S., Adra, N., Yorio, J., ...> ;European Urology Oncology. 2023 Dec 16
• 2 citations
  Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, ...
  Daniel J George, David R Spigel, Lucio N Gordan, Samith T Kochuparambil, Ana M Molina, Jeff Yorio, Arash Rezazadeh Kalebasty, Heidi McKean, Nishan Tchekmedyian, Scott ...> ;BMJ Open. 2022 Sep 14
• 4 citations
  Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
  Lindsey N. Teal, Jeffrey Yorio> ;Case Reports in Oncological Medicine. 2021 Mar 29
• 22 citations
  Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma.
  Sara Bedrose, Kevin C. Miller, Mohamed S Ali, Sameh Nassar, Naveen Garg, Marilyne Daher, Keith D. Eaton, Jeffrey Yorio, Davey B Daniel, Matthew Campbell, Keith C. Bibl...> ;Journal for Immunotherapy of Cancer. 2020 Jul 1
• 12 citations
  An interprofessionally developed geriatric oncology curriculum for hematology–oncology fellows
  Ahmed Eid, Caren L Hughes, Meghan Sri Karuturi, Connie Reyes, Jeffrey T. Yorio, Holly M. Holmes> ;Journal of Geriatric Oncology. 2015 Mar 1
• 3 citations
  Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barré syndrome: a case report
  Caren L Hughes, Jeffrey T. Yorio, Craig Kovitz, Yasuhiro Oki> ;Journal of Medical Case Reports. 2014 Dec 21
• 29 citations
  Case of vemurafenib-induced Sweet's syndrome
  Jeffrey T. Yorio, Steven R Mays, Ana M. Ciurea, Philip R. Cohen, Wei-Lien Wang, Wen-Jen Hwu, Nydia Gonzalez, Jessica L. Richard, Kevin B. Kim> ;The Journal of Dermatology. 2014 Sep 1
• 30 citations
  Influence of Medical Comorbidities on the Presentation and Outcomes of Stage I-III Non–Small-Cell Lung Cancer
  Daniel H. Ahn, Nishi Mehta, Jeffrey T. Yorio, Yang Xie, Jingsheng Yan, David E. Gerber> ;Clinical Lung Cancer. 2013 Nov 1
• 9 citations
  How have we diagnosed early-stage lung cancer without radiographic screening? A contemporary single-center experience.
  Evelyn O. Taiwo, Jeffrey T. Yorio, Jingsheng Yan, David E. Gerber> ;Plos One. 2012 Dec 21
• 58 citations
  Rare Though Not Mutually Exclusive: A Report of Three Cases of Concomitant KRAS and BRAF Mutation and a Review of the Literature.
  Ibrahim Halil Sahin, Syed Mohammad Ali Kazmi, Jeffrey T. Yorio, Nishin A. Bhadkamkar, Bryan K. Kee, Christo pher R Garrett> ;Journal of Cancer. 2013 Jan 1
• 3 citations
  A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas.
  Jeffrey T. Yorio, Nishin A. Bhadkamkar, Bryan K. Kee, Christopher R. Garrett> ;International Journal of Surgical Oncology. 2012 May 16
• 40 citations
  Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center
  Jeffrey T. Yorio, Jingsheng Yan, Yang Xie, David E. Gerber> ;Clinical Lung Cancer. 2012 Nov 1
• 73 citations
  Lung Cancer Diagnostic and Treatment Intervals in the United States: A Health Care Disparity?
  Jeffrey T. Yorio, Yang Xie, Jingsheng Yan, David E. Gerber> ;Journal of Thoracic Oncology. 2009 Nov 1
• The effect of a disease management algorithm and dedicated postacute coronary syndrome clinic on achievement of guideline compliance: results from the parkland acute c...
  Yorio, J., Viswanathan, S., See, R., Uchal, L., McWhorter, J. A., Spencer, N., Murphy, S., Khera, A., de Lemos, J. A., McGuire, D. K.> ;J Investig Med. 2008 Jan
• Join now to see all